Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

ClinicalTrials.gov ID: NCT05104983

Public ClinicalTrials.gov record NCT05104983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT05104983
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Darcy Krueger; Other
Enrollment: 64 participants

Conditions and interventions

Conditions

Interventions

Sirolimus Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 1 Day to 6 Months
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 12, 2021
Primary completion: Jun 29, 2026
Completion: Jun 29, 2027
Last update posted: Jan 21, 2026

2021 – 2027

United States locations

U.S. sites: 11
U.S. states: 10
U.S. cities: 11

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35294	Recruiting
University of California at Los Angeles	Los Angeles	California	90095	Recruiting
Stanford University	Palo Alto	California	94304	Recruiting
Children's Hospital Colorado	Aurora	Colorado	80045	Recruiting
Lurie Children's Hospital of Chicago	Chicago	Illinois	60611	Recruiting
Boston Children's Hospital	Boston	Massachusetts	02115	Recruiting
Washington University -- St. Louis	St Louis	Missouri	63110	Recruiting
University of North Carolina at Chapel Hill	Chapel Hill	North Carolina	27510	Active, not recruiting
Cincinnati Children's Hospital Medical Center	Cincinnati	Ohio	45229	Recruiting
University of Texas HSC at Houston	Houston	Texas	77030	Recruiting
Seattle Children's Hospital	Seattle	Washington	98105	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05104983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 21, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05104983 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →